Dr. Lal PathLabs (NSE:LALPATHLAB) Common Stock: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LALPATHLAB Dr. Lal PathLabs Ltd NSE:LALPATHLAB
95 GF Score
Price ₹1,904.40
GF Value ₹1,762.67
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Dr. Lal PathLabs Common Stock?

Dr. Lal PathLabs NSE:LALPATHLAB -1.56% 95 Common Stock is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:LALPATHLAB with a GF Score™ of 95/100 and a GF Value™ of ₹1,762.67 (Fairly Valued). The stock has 5 warning signs investors should review.

Dr. Lal PathLabs's quarterly common stock increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,676 Mil) but then declined from Mar. 2026 (₹1,676 Mil) to Jun. 2026 (₹0 Mil).

Dr. Lal PathLabs's annual common stock increased from Mar. 2024 (₹835 Mil) to Mar. 2025 (₹836 Mil) and increased from Mar. 2025 (₹836 Mil) to Mar. 2026 (₹1,676 Mil).

Dr. Lal PathLabs Common Stock Historical Data

* Premium members only.

The historical data trend for Dr. Lal PathLabs's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Lal PathLabs Common Stock Chart

Dr. Lal PathLabs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 833.45 833.68 834.78 835.92 1,675.55

Dr. Lal PathLabs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 838.00 0.00 1,675.55 0.00
NSE:LALPATHLAB
95GF Score
Dr. Lal PathLabs Ltd NSE:LALPATHLAB
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Lal PathLabs Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹0 Mil mean?
Dr. Lal PathLabs (NSE:LALPATHLAB) has a Common Stock of ₹0 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Dr. Lal PathLabs and its competitors.
Is Dr. Lal PathLabs' Common Stock too high?
Dr. Lal PathLabs' current Common Stock is ₹0 Mil. Overall, Dr. Lal PathLabs has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Lal PathLabs' Common Stock compare to TMO and DHR?
Dr. Lal PathLabs' Common Stock of ₹0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Dr. Lal PathLabs and its competitors. Dr. Lal PathLabs's current Common Stock is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Lal PathLabs stock overvalued right now?
Based on GuruFocus' analysis, Dr. Lal PathLabs (NSE:LALPATHLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,762.67, compared to a current price of ₹1,904.40 — trading 8% above its estimated fair value. The current Common Stock is ₹0 Mil. Dr. Lal PathLabs' overall GF Score™ is 95/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Dr. Lal PathLabs (NSE:LALPATHLAB), the current Common Stock is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Lal PathLabs stock appears to be overvalued. The current stock price of ₹1,904.40 is trading 8% above its estimated GF Value™ of ₹1,762.67. GuruFocus considers Dr. Lal PathLabs to be Fairly Valued.

Key valuation signals for NSE:LALPATHLAB:

  • Common Stock: ₹0 Mil
  • GF Value™: ₹1,762.67 vs. price of ₹1,904.40 (8% above fair value)
  • GF Score™: 95/100 with 5 warning signs

No single metric tells the full story. See the NSE:LALPATHLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Lal PathLabs Business Description

Other Exchanges 539524:India
Address 12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the areas of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist in preventing, monitoring, and treating diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
95GF Score

Get the complete analysis for NSE:LALPATHLAB

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,904.40
Price
₹1,762.67
GF Value